← Eichor
Study identifier: NCT07182968 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire

Condition: Systemic Sclerosis (SSc) · Systemic Sclerosis (Scleroderma) · Scleroderma (Limited and Diffuse)  ·  Sponsor: Hacettepe University

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic sclerosis (SSc) physically and has been validated for reliability and validity, as it correlates with the modified Rodnan Skin Score (mRSS), which rheumatologists assess. Thus, it has been demonstrated to be an applicable and easy approach for assessing skin thickness in SSc patients through patient-reported measurements. This study aimed to develop a Turkish version of the PASTUL questionnaire and to provide for its use in the Turkish population.

This description comes directly from the study's public registry record.

Talk to the study team

Orkun Tüfekçi, PT, PhD(c)  ·  5319502648  ·  orkuntf@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hacettepe UniversityÇankaya, Ankara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07182968